25-hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings

Journal of Infectious Diseases

Volumn 210, Issue 2, 2014, Pages 244-253

  Havers, Fiona ^a,h   Smeaton, Laura ^b   Gupte, Nikhil ^a,c   Detrick, Barbara ^a   Bollinger, Robert C ^a,b,c   Hakim, James ^d   Kumarasamy, Nagalingeswaran ^e   Andrade, Adriana ^a   Christian, Parul ^b   Lama, Javier R ^f   Campbell, Thomas B ^g   Gupta, Amita ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c B J MEDICAL COLLEGE   (India)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^e VHS Medical Centre India   (India)

^f ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^g UNIVERSITY OF COLORADO   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Asia

Indexed keywords

25 HYDROXYVITAMIN D; ANTIRETROVIRUS AGENT; ATAZANAVIR PLUS EMTRICITABINE PLUS DIDANOSINE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTUMN; BODY MASS; BRAZIL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SPRING; SUMMER; THAILAND; UNITED STATES; VIRUS LOAD; VITAMIN D DEFICIENCY; WINTER;

AFRICA; AMERICAS; ART; ASIA; HIV; MICRONUTRIENT; MORTALITY; VITAMIN D;

ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; TREATMENT FAILURE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84903955595     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu259     Document Type: Article

References (47)

1. Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc 2011; 71:50-61.
2. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3.
3. Khoo AL, Joosten I, Michels M, et al. 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology 2011; 134:459-68.
4. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010; 11:344-9.
5. Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170:5382-90. (Pubitemid 36617823)
6. Farnik H, Bojunga J, Berger A, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus (HBV) replication in chronically infected patients. Hepatology 2013; 58:1270-6.
7. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179:2060-3.
8. Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes 2008; 15:489-94.
9. Viard JP, Souberbielle JC, Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011; 25:1305-15.
10. Mehta S, Hunter DJ, Mugusi FM, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009; 200:1022-30.
11. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIVinfected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010; 5:e8770.
12. Sudfeld CR, Wang M, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy. PLoS One 2012; 7:e40036.
13. Sudfeld CR, Giovannucci EL, Isanaka S, et al. Vitamin D status and incidence of Pulmonary Tuberculosis, opportunistic infections, and wasting among HIV-Infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis 2013; 207:378-85.
14. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376:180-8.
15. Greene-Finestone LS, Berger C, de Groh M, et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 2011; 22:1389-99.
16. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81.
17. Sudfeld CR, Giovannucci EL, Isanaka S, et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-Infected tanzanian adults initiating antiretroviral therapy. J Infect Dis 2012; 207:378-85.
18. Campbell TB, Smeaton LM, Kumarasamy N, et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med 2012; 9: e1001290.
19. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986; 73:1-11.
20. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 2004; 37:867-74. (Pubitemid 39209026)
21. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011.
22. Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance, 2005. Available at: http://www.who.int/hiv/ pub/guidelines/clinicalstaging.pdf. Accessed 13 November 2013.
23. Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M. Using the whole cohort in the analysis of case-cohort data. Am J Epidemiol 2009; 169:1398-405.
24. Wiboonchutikul S, Sungkanuparph S, Kiertiburanakul S, et al. Vitamin D insufficiency and deficiency among HIV-1-Infected patients in a tropical setting. J Int Assoc Physicians AIDS Care (Chic) 2012; 11:305-10.
25. Nansera D, Graziano FM, Friedman DJ, BobbsMK, Jones AN, Hansen KE. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis 2011; 15:1522-7, i.
26. Mave V, Shere D, Gupte N, et al. Vitamin D deficiency is common among HIV-infected breastfeeding mothers in Pune, India, but is not associated with mother-to-child HIV transmission. HIV Clin Trials 2012; 13:278-83.
27. Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52:396-405.
28. Brown TT, McComsey GA. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010; 15:425-9.
29. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: Results from theMONET trial. AIDS Res Hum Retroviruses 2011; 27:29-34.
30. Welz T, Childs K, Ibrahim F, et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010; 24:1923-8.
31. Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr 2012; 108:1915-23.
32. Gao D, Trayhurn P, Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (London) 2013; 37:357-65.
33. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005; 35:217-24. (Pubitemid 40123868)
34. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179:1634-47.
35. Barber Y, Rubio C, Fernandez E, Rubio M, Fibla J. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users. J Infect Dis 2001; 184: 1279-88. (Pubitemid 33055572)
36. Nieto G, Barber Y, Rubio MC, Rubio M, Fibla J. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. J Steroid Biochem Mol Biol 2004; 89-90:199-207. (Pubitemid 38844283)
37. Bellamy R. Identifying genetic susceptibility factors for tuberculosis in Africans: a combined approach using a candidate gene study and a genome-wide screen. Clin Sci (London) 2000; 98:245-50. (Pubitemid 30145229)
38. Roth DE, Soto G, Arenas F, et al. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis 2004; 190:920-7. (Pubitemid 39120969)
39. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol 2011; 50:194-200.
40. Maxwell CS, Carbone ET, Wood RJ. Better newborn vitamin D status lowers RSV-associated bronchiolitis in infants. Nutr Rev 2012; 70:548-52.
41. Mandorfer M, Reiberger T, Payer BA, et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN-+RBV therapy in HIV/HCV coinfected patients. AIDS 2012; 27: 227-32.
42. Lake JE, Adams JS. Vitamin D in HIV-infected patients. Curr HIV/ AIDS Rep 2011; 8:133-41.
43. Campbell GR, Spector SA. Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog 2012; 8:e1003017.
44. Spector SA. Vitamin D and HIV: letting the sun shine in. Top Antivir Med 2011; 19:6-10.
45. Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIVinfected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011; 57:197-204.
46. Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B. Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health 2011; 11:853.
47. Harinarayan CV, Ramalakshmi T, Venkataprasad U. High prevalence of low dietary calcium and low vitamin D status in healthy south Indians. Asia Pac J Clin Nutr 2004; 13:359-64. (Pubitemid 40064066)